authors
- Reddy, Naveen Kumar
- Steinman, Michael A
- Joseph S. Ross, MD, MHS
- Widera, Eric
- Zeldes, Nina
- Steinbrook, Robert
- Ramachandran, Reshma
FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs.
- Overview
- Research
- Identity
- View All